The N-terminal of the estrogen receptor (ERα) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells
Authors:
- Filippa PetterssonFPFilippa Pettersson
- Marie-Claude CoutureMCMarie-Claude Couture
- Andre PaquinAPAndre Paquin
- Jacques GalipeauJGJacques Galipeau
- Sylvie MaderSMSylvie Mader
- Wilson H. MillerWMWilson H. Miller
- 1 July 2003
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 86 (1) , 1-14
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Diversity in the mechanisms of gene regulation by estrogen receptorsBioEssays, 2002
- Serine 157, a Retinoic Acid Receptor α Residue Phosphorylated by Protein Kinase C in Vitro, Is Involved in RXR·RARα Heterodimerization and Transcriptional ActivityJournal of Biological Chemistry, 1999
- p300 Interacts with the N- and C-terminal Part of PPARγ2 in a Ligand-independent and -dependent Manner, RespectivelyJournal of Biological Chemistry, 1999
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitroOncogene, 1997
- The efficacy of 9-cis retinoic acid in experimental models of cancerBreast Cancer Research and Treatment, 1996
- The RXR heterodimers and orphan receptorsCell, 1995
- Estrogen receptor‐negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acidJournal of Cellular Biochemistry, 1993
- A Prospective Study of the Intake of Vitamins C, E, and A and the Risk of Breast CancerNew England Journal of Medicine, 1993
- Binding of Retinoids to Human Breast Cancer Cell Lines and their Effects on Cell GrowthJournal of Clinical Investigation, 1980